FAT4 expression was lower in GC patients with lymph node metastasis (48.4%, or 137/283) than patients without lymph node metastasis (75.9%, or 126/166, P<0.05). This evidence concerns the gene FAT4 and metastatic malignant neoplasm in the lymph nodes.